Telix Pharmaceuticals says it has the formula to be a big cash-generating biotech for the long term.
Telix Pharmaceuticals has gone from the lab to global sales with a cancer imaging tool that will soon launch in Australia.
The boss of billion-dollar research company Telix,Christian Behrenbruch,is well aware that Australia’s promised ‘biotech boom’ will require more than government announcements.
Due to lower returns on the Australian sharemarket,only two of our eight racers finished the six-week race in the black